BioAmp Diagnostics
San Carlos, US · 1 known investors
BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections. The technology is intended to help physicians select the correct antibiotic and support efforts to combat antibiotic resistance.
Founders & leadership
Investors · 1
Frequently asked questions
- What does BioAmp Diagnostics do?
- BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections. The technology is intended to help physicians select the correct antibiotic and support efforts to combat antibiotic resistance.
- Who are BioAmp Diagnostics's investors?
- BioAmp Diagnostics's investors include Blue Bear Ventures.
- Where is BioAmp Diagnostics headquartered?
- BioAmp Diagnostics is headquartered in San Carlos, US.